Research

• Racial disparities in continuous glucose monitoring-based 60-min glucose predictions among people with type 1 diabetes (2024)

  Helene Bei Thomsen, Livie Yumeng Li, Anders A. Isaksen, and Adam Hulman

• Unraveling Uncertainty: The Impact of Biological and Analytical Variation on the Prediction Uncertainty of Categorical Prediction Models (2024)

  Remy J. H. Martens, William van Doorn, Mathie P G Leers, and Floris Helmich

• A comprehensive survey of artificial intelligence adoption in European laboratory medicine: current utilization and prospects (2024)

  Janne Cadamuro, Anna Carobene, Federico Cabitza, and Andrea Padoan

• Case Report: Laboratory detection of a thrombotic tendency in a family with hypodysfibrinogenemia and a novel FGG mutation (2024)

  Amaury Monard, Elisabetta Castoldi, Ilaria De Simone, and Yvonne Henskens

• Data flow in clinical laboratories: could metadata and peridata bridge the gap to new AI-based applications? (2024)

  Andrea Padoan, Janne Cadamuro, Glynis Frans, and Anna Carobene

• Differences in Cardiac Troponin T Composition in Myocardial Infarction and End-Stage Renal Disease Patients: A Blood Tube Effect? (2024)

  Wim Vroemen, Ellen Denessen, William van Doorn, and Alma M A Mingels

• The laboratory parameters-derived CoLab score as an indicator of the host response in ICU COVID-19 patients decreases over time: a prospective cohort study (2024)

  Tom Schoenmakers, Mathie P G Leers, Stefan H.M. Gorissen, and Andrea Peeters

• Machine learning for risk stratification in the emergency department (MARS-ED) study protocol for a randomized controlled pilot trial on the implementation of a prediction model based on machine learning technology predicting 31-day mortality in the emergency department (2024)

  Paul M.E.L. van Dam, William van Doorn, Floor van Gils, and Patricia M Stassen

• Deep embedded clustering generalisability and adaptation for integrating mixed datatypes: two critical care cohorts (2024)

  Jip de Kok, Frank van Rosmalen, Jacqueline Koeze, and Bas C. T. van Bussel

• The diurnal variation of Alzheimer’s disease plasma biomarkers: a 25h study with hourly sampling (2023)

  Wagner S. Brum, William van Doorn, Eduardo R. Zimmer, and Kaj Blennow

• Explainable Machine Learning Models for Rapid Risk Stratification in the Emergency Department: A Multicenter Study (2023)

  William van Doorn, Floris Helmich, Paul M E L van Dam, and Steven J R Meex

• Head-to-head comparison of 19 prediction models for short-term outcome in medical patients in the emergency department: a retrospective study (2023)

  Paul M. E. L. van Dam, Sien Lievens, Noortje Zelis, and Patricia M Stassen

• Evaluation of Innovative Laboratory Tests to Predict a Thrombotic Phenotype in a Family with Dysfibrinogenemia and a Novel FGG Mutation (2023)

  Amaury Monard, Floor Moenen, Elisabetta Castoldi, and Yvonne Henskens

• Large-language models binnen de klinische chemie (2023)

  William van Doorn, and Steef Kurstjens

• Deep embedded clustering generalisability and adaptation for mixed datatypes: two critical care cohorts (2023)

  Jip de Kok, Frank van Rosmalen, Jacqueline Koeze, and Bas van Bussel

• PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION. (2023)

  Amaury Monard, Fs.C.J.I. Heubel-Moenen, Elisabetta Castoldi, and Yvonne Henskens

• Direct Comparison of the Circadian Rhythm of Cardiac Myosin-Binding Protein C (cMyC) and Cardiac Troponin (2023)

  Bashir Alaour, Thomas Kaier, Rasmus Bo Hasselbalch, and Michael Marber

• Biological variation of Alzheimer’s disease plasma biomarkers in healthy individuals (2022)

  Wagner S. Brum, William van Doorn, Nicholas J. Ashton, and Kaj Blennow

• Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry (2022)

  Giulio Francesco Romiti, Marco Proietti, Marco Vitolo, and T. Pitt-Kerby

• High-Sensitivity Cardiac Troponin I and T Kinetics Differ following Coronary Bypass Surgery: A Systematic Review and Meta-Analysis (2022)

  Ellen Denessen, Samuel Heuts, Jean H.T. Daemen, and Alma M A Mingels

• Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry (2022)

  Giulio Francesco Romiti, Marco Proietti, Marco Vitolo, and T. Pitt-Kerby

• Diurnal Variations in Natriuretic Peptide Levels: Clinical Implications for the Diagnosis of Acute Heart Failure (2022)

  Tobias Breidthardt, William van Doorn, Noreen van der Linden, and Christian Mueller

• Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry (2022)

  Wern Yew Ding, Marco Proietti, Boriani Giuseppe, and T Pitt-Kerby

• Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry (2022)

  Wern Yew Ding, Marco Proietti, Boriani Giuseppe, and T Pitt-Kerby

• Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC‐EHRA EURObservational research programme in atrial fibrillation general long‐term registry (2022)

  Vincenzo Malavasi, Marco Vitolo, Marco Proietti, and T Pitt‐Kerby

• Impact of renal impairment on atrial fibrillation: ESC‐EHRA EORP‐AF Long‐Term General Registry (2022)

  Wern Yew Ding, Tatjana S Potpara, Carina Blomstrom, and T. Pitt‐Kerby

• Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry (2021)

  Marco Proietti, Marco Vitolo, Stephanie Harrison, and T. Pitt-Kerby

• Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry (2021)

  Marco Proietti, Marco Vitolo, Stephanie Harrison, and T. Pitt-Kerby

• Physiological circadian rhythm of cardiac myosin-binding protein C (cMyC) and cardiac troponin (2021)

  Bashir Alaour, Thomas Kaier, Zilan Demir, and S J R Meex

• Greater daily glucose variability and lower time in range assessed with continuous glucose monitoring are associated with greater aortic stiffness: The Maastricht Study (2021)

  Yuri D. Foreman, William van Doorn, Nicolaas Schaper, and Coen D. A. Stehouwer

• Proportions of circulating transitional B cells associate with MRI activity in interferon beta-treated multiple sclerosis patients (2021)

  Max Mimpen, Jan Damoiseaux, William van Doorn, and Joost Smolders

• Machine learning-based glucose prediction with use of continuous glucose and physical activity monitoring data: The Maastricht Study (2021)

  William van Doorn, Yuri D. Foreman, Nicolaas Schaper, and Martijn C. G. J. Brouwers

• Cardiac Troponin T: The Impact of Posttranslational Modifications on Analytical Immunoreactivity in Blood up to the Excretion in Urine (2021)

  Douwe de Boer, Alexander Streng, William van Doorn, and Alma M A Mingels

• A comparison of machine learning models versus clinical evaluation for mortality prediction in patients with sepsis (2021)

  William van Doorn, Patricia M Stassen, H.F. Borggreve, and Steven J. R. Meex

• Transparent Machine Learning models for Rapid Risk Stratification in the Emergency Department: A multi-center evaluation (2020)

  William van Doorn, Floris Helmich, Paul M.E.L. van Dam, and Steven J.R. Meex

• A comparison of machine learning models versus clinical evaluation for mortality prediction in patients with sepsis (2020)

  William van Doorn, Patricia M Stassen, H.F. Borggreve, and Steven J.R. Meex

• Testing for IgA anti-tissue transglutaminase in routine clinical practice: Requesting behaviour in relation to prevalence of positive results (2020)

  Maurits Damoiseaux, William van Doorn, Ellen van Lochem, and Jan Damoiseaux

• Role of sFlt-1 and PlGF in the screening of small-for-gestational age neonates during pregnancy: A systematic review (2019)

  Manouk Hendrix, Judith A P Bons, Ashlee van Haren, and Salwan Al-Nasiry

• Biotin interference in high-sensitivity cardiac troponin T testing: a real-world evaluation in acute cardiac care (2019)

  Wim Vroemen, William van Doorn, Dorien Kimenai, and Steven J R Meex

• High-Sensitivity Cardiac Troponin I and T Kinetics after Non-ST-Segment Elevation Myocardial Infarction (2019)

  William van Doorn, Wim Vroemen, Martijn W Smulders, and Steven J.R. Meex

• Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry (2019)

  Cyril Zakine, Rodrigue Garcia, Kumar Narayanan, and T Pitt-Kerby

• Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry (2019)

  Boriani Giuseppe, Marco Proietti, Cécile Laroche, and T Pitt-Kerby

• Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry (2018)

  Boriani Giuseppe, Marco Proietti, Cécile Laroche, and T Pitt-Kerby

• Clinical laboratory practice recommendations for high-sensitivity cardiac troponin testing (2018)

  William van Doorn, Wim Vroemen, Douwe de Boer, and Steven J. R. Meex

• Twenty-Four-Hour Biological Variation Profiles of Cardiac Troponin I in Individuals with or without Chronic Kidney Disease (2017)

  Noreen van der Linden, Judith Hilderink, Tom Cornelis, and Steven J.R. Meex

• Identification and Characterization of Cardiac Troponin T Fragments in Serum of Patients Suffering from Acute Myocardial Infarction (2016)

  Alexander Streng, Douwe de Boer, William van Doorn, and Will Wodzig

• Cardiac troponin T degradation in serum is catalysed by human thrombin (2016)

  Alexander Streng, Douwe de Boer, William van Doorn, and Will Wodzig

• The SAMe-TT2R2 score and quality of anticoagulation in atrial fibrillation: a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists (2015)

  Wern Yew Ding, Tatjana S Potpara, Carina Blomstrom, and D. Angoulvant